CBI’s annual Pharmaceutical Compliance Congress featured industry leaders and government representatives espousing the usual best practices for building and maintaining an effective compliance program, but this year’s agenda offered a few surprises and changes in the regulatory wind. This new infographic lists our key points and top takeaways from a full agenda of panel sessions and presentations.